The Anaphylaxis Treatment Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market for anaphylaxis treatment has seen robust growth in the past. The market size is predicted to increase from $6.19 billion in 2024 to $6.61 billion in 2025, indicating a compound annual growth rate (CAGR) of 6.9%.
The Anaphylaxis Treatment Global Market is forecasted to grow to a size of $8.72 billion by the year 2029. The projected Compound Annual Growth Rate (CAGR) for this market is 7.2%.
Download Your Free Sample of the 2025 Anaphylaxis Treatment Market Report and Uncover Key Trends Now!The key drivers in the anaphylaxis treatment market are:
• Innovation in biologic therapies contributes to the growth.
• Global efforts on food safety drive the expansion.
• Empowering patients and patient advocacy foster market growth.
• Enhanced emergency medical services are propelling growth.
The anaphylaxis treatment market covered in this report is segmented –
1) By Treatment: Epinephrine, Antihistamines, Steroids, Beta-antagonists, Other Treatments
2) By Product: Tablets, Capsules, Other Products
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
4) By Application: Food Allergy, Pollen Allergy, Dust Mites Allergy, Other Applications
The key trends in the anaphylaxis treatment market are:
• Innovation in auto-injectors is emerging as one of the significant trends.
• Telemedicine is increasingly being used for managing anaphylaxis.
• Allergen immunotherapy is improving and gaining traction.
• The use of biometric wearables for allergen detection and collaborations in allergy research is rising.
The major players in the anaphylaxis treatment market are:
• Merck & Co
North America was the largest region in the anaphylaxis treatment market in 2024